Erratum: Nanotechnology in Wound Healing; Semisolid Dosage Forms Containing Curcumin-Ampicillin Solid Lipid Nanoparticles, in Vitro, Ex Vivo and in Vivo Characteristics (Advanced Pharmaceutical Bulletin (2018) 8:3 (395-400) Doi: 10.15171/Apb.2018.046) Publisher



Ghaffari S^{1, 2} ; Alihosseini F¹ ; Sorkhabadi SMR^{1, 3, 4} ; Bidgoli SA^{1, 5} ; Mousavi SE⁶ ; Haghighat S⁷ ; Nasab AA¹ ; Kianvash N²
Source: Advanced Pharmaceutical Bulletin Published:2021

Abstract

This erratum is issued to amend the version of record of Nanotechnology in Wound Healing; Semisolid Dosage Forms Containing Curcumin-Ampicillin Solid Lipid Nanoparticles, in-Vitro, Ex-Vivo and in-Vivo Characteristicspublished in Advanced Pharmaceutical Bulletin, 2018, 8(3), 395-400. doi: 10.15171/apb.2018.046 The journal's editorial staff introduced a number of textual and typographical changes to the earlier version of the published article text. These changes were approved by the authors, and resulted in an improved readability level of the text as well as some shifts in the scientific meaning of the submitted work. By issuing the correction, Advanced Pharmaceutical Bulletinhopes that the readability and the original meaning and emphasis will be restored, and so allow readers the full benefit of this research. The journal has taken steps to ensure that measures are in place to avoid publishing an incorrect version of an article in the future. The Advanced Pharmaceutical Bulletinapologizes for these errors and any consequent inconvenience to the readers. The article was corrected online. © 2021 The Author (s).